Moleculin Biotech (MBRX) Tops Q1 EPS by 209c

Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.69), $2.09 better than the analyst estimate of ($2.78).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Wendy's U.S. president to resign, company to create COO role
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low